Aileron Therapeutics
Aileron Therapeutics is an American biopharmaceutical company based in Cambridge, Massachusetts.
Organization
Personnel
| Aileron Therapeutics - Team | ||
|---|---|---|
| Name | Position | Notes |
| Loren Walensky | Scientific Advisory Board member and consultant1) | Married to Rochelle Walensky; employed at Dana-Farber Cancer Institute; Scientific Co-founder of Lytica Therapeutics |
Investors
Investors in Aileron Therapeutics include:2) 3) 4) 5)
- Novartis Venture Fund (NVF)
External links
1)
Mourtada, R., Herce, H. D., Yin, D. J., Moroco, J. A., Wales, T. E., Engen, J. R., & Walensky, L. D. (2019). Design of stapled antimicrobial peptides that are stable, nontoxic and kill antibiotic-resistant bacteria in mice. Nature Biotechnology, 37(10), 1186–1197. https://doi.org/10.1038/s41587-019-0222-z
2)
Aileron Therapeutics - Funding, Financials, Valuation & Investors. Crunchbase. Retrieved May 11, 2023, from https://www.crunchbase.com/organization/aileron-therapeutics/company_financials
3)
Series A - Aileron Therapeutics - 2006-12-01 - Crunchbase Funding Round Profile. Crunchbase. Retrieved May 11, 2023, from https://www.crunchbase.com/funding_round/aileron-therapeutics-series-a--f1823f7a
4)
Series D - Aileron Therapeutics - 2009-06-11 - Crunchbase Funding Round Profile. Crunchbase. Retrieved May 11, 2023, from https://www.crunchbase.com/funding_round/aileron-therapeutics-series-d--7c3c2e71
5)
Series E - Aileron Therapeutics - 2014-10-29 - Crunchbase Funding Round Profile. Crunchbase. Retrieved May 11, 2023, from https://www.crunchbase.com/funding_round/aileron-therapeutics-series-e--740ce9be